Modeling the Health and Economic Impact of Pharmacologic Therapies for MASLD in the United States
{{output}}
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common condition leading to chronic liver disease which generates substantial health care costs. Our aim was to model the impact on diseas... ...
